[go: up one dir, main page]

HUP9904075A3 - Composition, for the treatment of asthma,containing loratadine and a decongestant - Google Patents

Composition, for the treatment of asthma,containing loratadine and a decongestant

Info

Publication number
HUP9904075A3
HUP9904075A3 HU9904075A HUP9904075A HUP9904075A3 HU P9904075 A3 HUP9904075 A3 HU P9904075A3 HU 9904075 A HU9904075 A HU 9904075A HU P9904075 A HUP9904075 A HU P9904075A HU P9904075 A3 HUP9904075 A3 HU P9904075A3
Authority
HU
Hungary
Prior art keywords
decongestant
asthma
treatment
composition
containing loratadine
Prior art date
Application number
HU9904075A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HUP9904075A2 publication Critical patent/HUP9904075A2/hu
Publication of HUP9904075A3 publication Critical patent/HUP9904075A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9904075A 1996-10-31 1997-10-29 Composition, for the treatment of asthma,containing loratadine and a decongestant HUP9904075A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31

Publications (2)

Publication Number Publication Date
HUP9904075A2 HUP9904075A2 (hu) 2000-05-28
HUP9904075A3 true HUP9904075A3 (en) 2002-02-28

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904075A HUP9904075A3 (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma,containing loratadine and a decongestant

Country Status (21)

Country Link
EP (1) EP0941091A1 (es)
JP (1) JP2000505104A (es)
KR (1) KR20000052922A (es)
CN (1) CN1235545A (es)
AR (1) AR008908A1 (es)
AU (1) AU731756B2 (es)
BR (1) BR9712705A (es)
CA (1) CA2268546A1 (es)
CO (1) CO4910128A1 (es)
CZ (1) CZ150999A3 (es)
HU (1) HUP9904075A3 (es)
ID (1) ID23431A (es)
IL (1) IL129662A0 (es)
NO (1) NO992062D0 (es)
NZ (1) NZ335078A (es)
PE (1) PE11399A1 (es)
PL (1) PL333056A1 (es)
SK (1) SK54599A3 (es)
TR (1) TR199901003T2 (es)
WO (1) WO1998018470A1 (es)
ZA (1) ZA979731B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2307790A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
AR022378A1 (es) * 1998-09-10 2002-09-04 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
EP1154762B1 (en) * 1999-02-23 2003-11-05 Yuhan Corporation Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
AU3924500A (en) * 1999-03-29 2000-10-16 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
SK287684B6 (sk) * 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
JP5592042B2 (ja) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ,インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬/鬱血除去薬製剤
AU2001264806A1 (en) * 2000-05-25 2001-12-03 Schering Corporation Stable liquid and solid formulations
CN1518448A (zh) * 2001-06-20 2004-08-04 ���鹫˾ 用于治疗鼻充血和鼻塞的抗组胺剂
NZ541960A (en) * 2005-06-17 2010-01-29 Aft Pharmaceuticals Ltd Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
RU2423979C2 (ru) * 2005-06-17 2011-07-20 АФТ Фармасьютикалз Лимитед Новая фармацевтическая композиция и ее применение в способе лечения пациентов с гиперемией и отеком слизистой оболочки верхних дыхательных путей
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
BRPI0712532A2 (pt) * 2006-06-01 2013-04-02 Schering Plough Healthcare Prod Inc formulaÇÕes e composiÇÕes farmacÊuticas de fenilefrina para absorÇço colânica
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
AR008908A1 (es) 2000-02-23
EP0941091A1 (en) 1999-09-15
KR20000052922A (ko) 2000-08-25
ZA979731B (en) 1998-04-29
NO992062L (no) 1999-04-29
NO992062D0 (no) 1999-04-29
AU731756B2 (en) 2001-04-05
AU4995397A (en) 1998-05-22
JP2000505104A (ja) 2000-04-25
CA2268546A1 (en) 1998-05-07
NZ335078A (en) 2000-10-27
PE11399A1 (es) 1999-02-09
TR199901003T2 (xx) 1999-07-21
CN1235545A (zh) 1999-11-17
CO4910128A1 (es) 2000-04-24
PL333056A1 (en) 1999-11-08
IL129662A0 (en) 2000-02-29
SK54599A3 (en) 2000-08-14
CZ150999A3 (cs) 1999-10-13
BR9712705A (pt) 1999-10-26
WO1998018470A1 (en) 1998-05-07
HUP9904075A2 (hu) 2000-05-28
ID23431A (id) 2000-04-20

Similar Documents

Publication Publication Date Title
NZ294392A (en) Asthma drugs and compounds
AU133903S (en) Inhaler device
HUP9904075A3 (en) Composition, for the treatment of asthma,containing loratadine and a decongestant
HRP960365B1 (en) New medicaments and the use thereof
GB9606805D0 (en) Medicaments
GB9611947D0 (en) Medicaments
GB2322568B (en) Gas treatment devices
GB9618974D0 (en) Medicaments
IL130348A0 (en) Imidazopyridazines and medicaments containing the same
PL322596A1 (en) Antiglucocorticoid drug
GB9605293D0 (en) Medicaments
HUP9701618A3 (en) Pharmaceutical composition containing tramadol and a calcium-canal-antagonist
GB9522178D0 (en) Material treatment
GB2355006B (en) Materials treatment
GB9415901D0 (en) Novel compounds and treatment
GB9606721D0 (en) Infusion packages and methods for their manufacture
HUP0103569A3 (en) New medicament and process for its preparation
HK1018941A (en) Composition, for the treatment of asthma, containing loratadine and a decongestant
GB9415900D0 (en) Novel compounds and treatment
GB9611167D0 (en) Medicaments
IL125286A0 (en) Phenanthridine compounds medicaments containing the same and use thereof
HUP0003908A3 (en) Use of substituted azaspirane in the manufacture of a medicament for use in treating asthma
GB9423356D0 (en) Oral treatment
GB9613096D0 (en) Medicaments
GB9727276D0 (en) Improvements in medicaments for asthma treatment